Evaluation of Defined Daily Dose, Percentage of British National Formulary Maximum and Chlorpromazine Equivalents in Antipsychotic Drug Utilization

Objective
The present study was carried out to investigate and compare the three methods for calculating total antipsychotic dose among outpatients with schizophrenia attending primary psychiatric health care centers. The three methods were: Defined Daily Doses (DDDs), chlorpromazine equivalents (CPZeq) and percentages of the British National Formulary (BNF) maximum.
Methodology
Antipsychotic drug dosing data for 250 patients with schizophrenia were investigated by calculating Spearman’s rank correlation coefficients. Factors associated with antipsychotic dose, expressed as DDDs, CPZeq and percentages of the BNF maximum recommended daily dose, were investigated by means of linear regression analysis.
Results
Spearman’s correlation showed that there is a significant relationship between all pairs of the three dosing methods. In all three methods, coherence was strongest when dealing with first generation antipsychotics (FGA). Linear regression analyses showed a high degree of coherence between antipsychotic doses expressed as DDDs, CPZeq and percentages of the BNF maximum recommended daily dose.
Conclusion
All three tested methods are reliable and coherent for calculating antipsychotic dosing.

Abbreviations

  • %BNFmax, percentage of British National Formulary maximum;
  • CPZeq, chlorpromazine equivalents;
  • DDD, Defined Daily Dose (DDD);
  • FGA, first generation antipsychotics;
  • SGA, second generation antipsychotics
Journal
Title
Saudi Pharmaceutical Journal Available online 6 April 2013 http://dx.doi.org/10.1016/j.jsps.2013.03.003
Publisher
Elsevier
Publisher Country
United States of America
Indexing
Thomson Reuters
Impact Factor
2.302
Publication Type
Both (Printed and Online)
Volume
22
Year
2014
Pages
127-32